Skip to main content
OpenTrials
Active, Not Recruiting

NCT Number: NCT07650513

Awareness of Prediabetes Among Physicians

Prediabetes is associated with impaired fasting glucose and/or impaired glucose tolerance. Recent data indicate that more than one-third of adults in affluent countries have prediabetes . Fasting glucose concentrations of 100-125 mg/dL, hemoglobin A1c (HbA1c) titers of 5.7-6.4%, and two-hour post-stimulus glucose levels of 140-199 mg/dL are used to identify prediabetes. Behavioral lifestyle changes and medications are useful in preventing the progression of prediabetes to T2DM .

Early detection and treatment of T2DM and prediabetes can prevent future health problems. However, many people with metabolic disorders are undiagnosed, partly due to the clinical practices and knowledge of primary care physicians (PCPs). PCPs play a critical role in diabetes prevention through the detection and management of prediabetes. Successful screening initiatives and the start of appropriate management interventions depend on PCPs' level of prediabetes knowledge Most patients with prediabetes do not receive evidence-based preventive care from their PCPs . Systemic barriers hinder physicians' ability to provide the best evidence-based practice, such as performance measures, insurance reimbursement, cultural expectations, and a lack of tools and staffing resources

Active, Not Recruiting

This study is active but is not currently recruiting participants.

Notify Me

Key information

Age range

25 year and older

Sex eligibility

All sexes

Study type

Observational

Primary location

Sohag University Faculty of Medicine

Sohag, Egypt

Who can participate

Only the study team can determine whether someone qualifies for participation.

Inclusion criteria

  • - Physicians working at Sohag government hospitals and clinics
  • Faculty medical staff (any specialty)
  • Willing to complete the self-administered questionnaire
  • Provide informed written consent to participate in the study

Exclusion criteria

1 - Physicians who decline to provide informed consent.

2-Physicians who do not complete at least 90% of the questionnaire items.

3-Physicians not actively practicing at a Sohag government hospital or clinic during the study period.

Treatment and study plan

Primary outcomes

  1. Physician awareness of prediabetes risk factors, diagnostic criteria, and management recommendations

    Time frame: Single time point during data collection period (April 1, 2026 to June 30, 2026)

    Proportion of physicians who correctly identify: (1) risk factors for diabetes screening (e.g., age ≥35, BMI ≥25 kg/m², hypertension, family history of diabetes), (2) fasting glucose diagnostic cut-offs for prediabetes (100-125 mg/dL) and diabetes (≥126 mg/dL), (3) HbA1c cut-offs for prediabetes (5.7-6.4%) and diabetes (≥6.5%), (4) lifestyle modification recommendations for prediabetes (minimum 7% weight loss and 150 minutes of physical activity per week), and (5) appropriate use of metformin for prediabetes prevention.Validated structured self-administered questionnaire (adapted from Tseng et al., 2019) distributed via Google Forms, including multiple-choice and true/false questions

Sponsors and collaborators

Lead sponsor

Sohag University

Other

Registry information

Important dates

Study start
2026
Primary completion
2026
Study completion
2026
First posted
Jun 16, 2026
Registry last updated
Jun 16, 2026

OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.

View the official ClinicalTrials.gov record (opens in a new tab)

This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.

Published trials that share one or more normalized conditions with this study.